Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 5
2011 5
2012 8
2013 12
2014 9
2015 7
2016 8
2017 16
2018 14
2019 15
2020 8
2021 16
2022 12
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean relate pichler (11 results)?
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF; KEYNOTE-045 Investigators. Bellmunt J, et al. N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17. N Engl J Med. 2017. PMID: 28212060 Free PMC article. Clinical Trial.
Drug-Drug Interactions in Prostate Cancer Treatment.
Hebenstreit D, Pichler R, Heidegger I. Hebenstreit D, et al. Among authors: pichler r. Clin Genitourin Cancer. 2020 Apr;18(2):e71-e82. doi: 10.1016/j.clgc.2019.05.016. Epub 2019 May 27. Clin Genitourin Cancer. 2020. PMID: 31677899 Review.
Short review of biparametric prostate MRI.
Steinkohl F, Pichler R, Junker D. Steinkohl F, et al. Among authors: pichler r. Memo. 2018;11(4):309-312. doi: 10.1007/s12254-018-0458-1. Epub 2018 Nov 12. Memo. 2018. PMID: 30595756 Free PMC article. Review.
Lynch Syndrome: Its Impact on Urothelial Carcinoma.
Lindner AK, Schachtner G, Tulchiner G, Thurnher M, Untergasser G, Obrist P, Pipp I, Steinkohl F, Horninger W, Culig Z, Pichler R. Lindner AK, et al. Among authors: pichler r. Int J Mol Sci. 2021 Jan 7;22(2):531. doi: 10.3390/ijms22020531. Int J Mol Sci. 2021. PMID: 33430305 Free PMC article. Review.
Editorial: Immune checkpoint inhibitors in renal cell carcinoma.
Tykodi SS, Pichler R. Tykodi SS, et al. Among authors: pichler r. Front Oncol. 2023 Apr 18;13:1203463. doi: 10.3389/fonc.2023.1203463. eCollection 2023. Front Oncol. 2023. PMID: 37143949 Free PMC article. No abstract available.
Rare, but Severe: Vasculitis and Checkpoint Inhibitors.
Lindner AK, Gruenbacher G, Schachtner G, Thurnher M, Pichler R. Lindner AK, et al. Among authors: pichler r. Eur Urol Focus. 2020 May 15;6(3):609-612. doi: 10.1016/j.euf.2019.04.014. Epub 2019 May 6. Eur Urol Focus. 2020. PMID: 31072806 Review.
136 results